Diabetes Research in Clinical Practice

Novel helpful targets accessible for diabetes incorporates Incretion based treatments, oral remedial specialists like secretagogues, beta cell recovery and expansion and foundational microorganism treatments. Early stage immature microorganism and fatal antecedent cell transplantation treatments are the significant undifferentiated cell treatments accessible for Diabetes. Aside from the abovementioned, different computational methodologies in Diabetes the executives control have been presented as of late which are assuming a significant job in distinguishing proof of qualities causing diabetes helping in Early Detection of Diabetes. These procedures are additionally valuable in contemplating the substance etioslogies of Diabetes revealing different treatment prospects and model development forms for endurance expectation.

  • Updates of anti-diabetic agents
  • Incretin based therapies
  • Oral therapies: secretagogues
  • Diabetes and cancer
  • Non-invasive diagnostic tool for detecting cardiovascular disease in diabetes
  • Diabetes Case Reports
  • Measurement of insulin resistance and secretion in diabetes clinic
  • Novel agents in treatment

Related Conference of Diabetes Research in Clinical Practice

March 25-26, 2024

5th Annual Conference on Diabetes

London, UK
July 11-12, 2024

7th Annual Meeting on Diabetes and Endocrinology

Paris, France
September 09-10, 2024

4th European Endocrinology and Diabetes Congress

Paris, France
November 22-23, 2024

20th World Congress on Endocrinology & Diabetes

Amsterdam, Netherlands

Diabetes Research in Clinical Practice Conference Speakers

    Recommended Sessions

    Related Journals

    Are you interested in